Evidence map›Paper›PMID 29665256›Full record

ArticleCancer medicine2018

BCR-ABL enhances the prolyl isomerase activity of Pin 1 by interacting with DAPK1 in ph

Wen-Bin Cao, Jian-Feng Yao, Si-Zhou Feng, Yi He, Er-Lie Jiang, Rong-Li Zhang, Dong-Lin Yang, Ming Gong, Xiao-Hui Zheng, Shu-Lian Chen and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Wen-Bin CaoHematopoietic Stem Cell Transplantation Center, Institute of Hematology and Blood Diseases Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, No. 288 Nanjing Road, 300020, Tianjin, China.
Jian-Feng YaoHematopoietic Stem Cell Transplantation Center, Institute of Hematology and Blood Diseases Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, No. 288 Nanjing Road, 300020, Tianjin, China.
Si-Zhou FengHematopoietic Stem Cell Transplantation Center, Institute of Hematology and Blood Diseases Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, No. 288 Nanjing Road, 300020, Tianjin, China.
Yi HeHematopoietic Stem Cell Transplantation Center, Institute of Hematology and Blood Diseases Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, No. 288 Nanjing Road, 300020, Tianjin, China.
Er-Lie JiangHematopoietic Stem Cell Transplantation Center, Institute of Hematology and Blood Diseases Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, No. 288 Nanjing Road, 300020, Tianjin, China.
Rong-Li ZhangHematopoietic Stem Cell Transplantation Center, Institute of Hematology and Blood Diseases Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, No. 288 Nanjing Road, 300020, Tianjin, China.
Dong-Lin YangHematopoietic Stem Cell Transplantation Center, Institute of Hematology and Blood Diseases Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, No. 288 Nanjing Road, 300020, Tianjin, China.
Ming GongHematopoietic Stem Cell Transplantation Center, Institute of Hematology and Blood Diseases Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, No. 288 Nanjing Road, 300020, Tianjin, China.
Xiao-Hui ZhengHematopoietic Stem Cell Transplantation Center, Institute of Hematology and Blood Diseases Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, No. 288 Nanjing Road, 300020, Tianjin, China.
Shu-Lian ChenHematopoietic Stem Cell Transplantation Center, Institute of Hematology and Blood Diseases Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, No. 288 Nanjing Road, 300020, Tianjin, China.
Jia-Li SunHematopoietic Stem Cell Transplantation Center, Institute of Hematology and Blood Diseases Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, No. 288 Nanjing Road, 300020, Tianjin, China.
Lu-Kun ZhouHematopoietic Stem Cell Transplantation Center, Institute of Hematology and Blood Diseases Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, No. 288 Nanjing Road, 300020, Tianjin, China.
Ming-Zhe HanHematopoietic Stem Cell Transplantation Center, Institute of Hematology and Blood Diseases Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, No. 288 Nanjing Road, 300020, Tianjin, China.ORCID 0000-0002-9769-8577
Chinese Academy of Medical Sciences & Peking Union Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Philadelphia chromosome (Ph)/BCR-ABL-positive (ph

Indexed as

AdolescentAdultApoptosisCell Line, TumorCell ProliferationDeath-Associated Protein KinasesEnzyme ActivationFemaleFusion Proteins, bcr-ablHumansImatinib MesylateMaleMiddle AgedNIMA-Interacting Peptidylprolyl IsomerasePrecursor Cell Lymphoblastic Leukemia-LymphomaProtein BindingDAPK1 protein, humanDeath-Associated Protein KinasesFusion Proteins, bcr-ablImatinib MesylateNIMA-Interacting Peptidylprolyl IsomerasePIN1 protein, humanALLBCR-ABLDAPK1Pin 1protein-protein interaction

Identifiers

PMID29665256
PMCPMC6010889
OpenAlexW2800664052

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.